Navigation Links
Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
Date:10/31/2008

SHANGHAI, China, Oct. 31 /Xinhua-PRNewswire/ -- Sundia MediTech Company, a Shanghai-based drug discovery and pharmaceutical development outsourcing service company (CRO) received this year's Deloitte Technology Fast 50 China award, and ranked number 16. The result of Deloitte Technology Fast 50 China Program was announced today in Shenzhen, China at a special ceremony.

Deloitte Technology Fast 50 Program started in 1995 in San Jose. This program quickly expanded to numerous cities and countries. In 2005, Deloitte China launched the "Deloitte Technology Fast 50 China" program. Participants in the Deloitte Technology Fast 50 China program will automatically qualify for participation in the Deloitte Technology Fast 500 Asia Pacific 2008 program, which annually recognises the 500 fastest growing technology companies in Asia Pacific.

Sundia was named consecutively in 2007 and 2008 as one of the top 50 most valuable companies for investment in China. About the Deloitte Technology Fast award, Dr. Xiaochuan Wang, Sundia's CEO said "it is another recognition of Sundia's achievement, and also recognition of China's CRO industry development."

Sudia has kept a high speed for business growth in the 4 and half year history of the company. Last year, Sundia successfully merged with another CRO company United Pharmatech Company in Shanghai. According to Dr. Shi Xiongwei, the founder of United Pharmatech and now Executive VP of Sundia, the company has expanded its business scope from the original chemistry service area to cover most drug discovery and pharmaceutical development areas. The company has made significant contribution to some new drug development programs for clients. Through closely working with client companies, they have successfully advanced a few programs to preclinical or clinical stage.

Sundia's CFO Mr. Beijia Yu and Vice President Dr. Jiong Chen attended today's ceremony to receive "Deloitte Technology Fast 50 China" award.

About the Company

Sundia MediTech Company was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide drug discovery and pharmaceutical development CRO services to clients worldwide. Over the past 4 years, Sundia has built a strong reputation in its field.


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
2. Abt Associates Ranked One of Top 20 U.S. Market Research Firms
3. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
4. Alma Lasers Ranked 9th in Deloitte Technology Fast 50 Award
5. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
6. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
7. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
8. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
9. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
10. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2008 Washington State Technology Fast 50 for 5th Time in Past 7 Years
11. In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... announced the launch of the Supplyframe Design Lab . Located in Pasadena, ... explore the future of how hardware projects are designed, built and brought to ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... -- Perkotek an innovation leader in attendance control systems is proud to announce the introduction ... to make sure the right employees are actually signing in, and to even control ... ... ... ...
Breaking Biology News(10 mins):